Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

AU Dignass; S Stoynov; AE Dorofeyev; GA Grigorieva; E Tomsova; I Altorjay; D Tuculanu; I Bunganic; J Pokrotnieks; L Kupcinskas; R Greinwald; R Mueller

doi:10.1016/S0016-5085(13)60823-9

Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

AU Dignass, S Stoynov, AE Dorofeyev, GA Grigorieva, E Tomsova, I Altorjay, D Tuculanu, I Bunganic, J Pokrotnieks, L Kupcinskas, R Greinwald, R Mueller

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	Sa1217
Pages (from-to)	S233
Journal	Gastroenterology
Volume	144
Issue number	5, Suppl.1
DOIs	https://doi.org/10.1016/S0016-5085(13)60823-9
Publication status	Published - May 2013
Externally published	Yes
Event	Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2013) - Orlando, United States Duration: 18 May 2013 → 21 May 2013 https://www.medscape.com/viewcollection/32834

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

10.1016/S0016-5085(13)60823-9

Cite this

Dignass, AU., Stoynov, S., Dorofeyev, AE., Grigorieva, GA., Tomsova, E., Altorjay, I., Tuculanu, D., Bunganic, I., Pokrotnieks, J., Kupcinskas, L., Greinwald, R., & Mueller, R. (2013). Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study. Gastroenterology, 144(5, Suppl.1), S233. Article Sa1217. https://doi.org/10.1016/S0016-5085(13)60823-9

@article{27134cfb88264cef8f975d6a17c3e436,

title = "Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study",

author = "AU Dignass and S Stoynov and AE Dorofeyev and GA Grigorieva and E Tomsova and I Altorjay and D Tuculanu and I Bunganic and J Pokrotnieks and L Kupcinskas and R Greinwald and R Mueller",

year = "2013",

month = may,

doi = "10.1016/S0016-5085(13)60823-9",

language = "English",

volume = "144",

pages = "S233",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "5, Suppl.1",

note = "Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) {"}Digestive Disease Week{"} (DDW 2013), DDW 2013 ; Conference date: 18-05-2013 Through 21-05-2013",

url = "https://www.medscape.com/viewcollection/32834",

}

Dignass, AU, Stoynov, S, Dorofeyev, AE, Grigorieva, GA, Tomsova, E, Altorjay, I, Tuculanu, D, Bunganic, I, Pokrotnieks, J, Kupcinskas, L, Greinwald, R & Mueller, R 2013, 'Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study', Gastroenterology, vol. 144, no. 5, Suppl.1, Sa1217, pp. S233. https://doi.org/10.1016/S0016-5085(13)60823-9

Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study. / Dignass, AU; Stoynov, S; Dorofeyev, AE et al.
In: Gastroenterology, Vol. 144, No. 5, Suppl.1, Sa1217, 05.2013, p. S233.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease

T2 - Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2013)

AU - Dignass, AU

AU - Stoynov, S

AU - Dorofeyev, AE

AU - Grigorieva, GA

AU - Tomsova, E

AU - Altorjay, I

AU - Tuculanu, D

AU - Bunganic, I

AU - Pokrotnieks, J

AU - Kupcinskas, L

AU - Greinwald, R

AU - Mueller, R

PY - 2013/5

Y1 - 2013/5

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000322997201216

U2 - 10.1016/S0016-5085(13)60823-9

DO - 10.1016/S0016-5085(13)60823-9

M3 - Meeting Abstract

SN - 0016-5085

VL - 144

SP - S233

JO - Gastroenterology

JF - Gastroenterology

IS - 5, Suppl.1

M1 - Sa1217

Y2 - 18 May 2013 through 21 May 2013

ER -

Dignass AU, Stoynov S, Dorofeyev AE, Grigorieva GA, Tomsova E, Altorjay I et al. Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study. Gastroenterology. 2013 May;144(5, Suppl.1):S233. Sa1217. doi: 10.1016/S0016-5085(13)60823-9

Once Daily Dosing of 9mg Budesonide (Budenofalk (R)) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this